Women’s Health Nurse Practitioner Exam Prep

Answer: A - Fetal hydantoin syndrome (which includes craniofacial anomalies, fetal growth deficiency, developmental delay, fingernail hypoplasia, cardiac anomalies and facial clefts) is an established risk of dilantin use in pregnancy. Fetal neural tube defects are associated with the use of the anti-seizure medication valproate; fetal skeletal defects are theoretically associated with the use of the anti-seizure medication keppra.